Pharma Archives - Page 92 of 99 - Boston Life Sciences Times

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

September 1, 2026

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

August 31, 2026

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

August 28, 2026

THIS WEEK'S STORIES

TransCode Reports Preclinical Survival Benefit for TTX-MC138 in Breast Cancer Bone Metastasis

August 31, 2026

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

August 31, 2026

Transfyr Launches Physical AI Platform for Science With $25 Million in Seed Funding

August 26, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Scholar Rock Gets FDA Fast Track Designation for Apitegromab in FSHD as Phase 2 Trial Begins

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Most Read

Treeline, Roche to Test TLN-121 With Bispecific Antibodies in B-Cell Lymphomas

RevBio Study Finds TETRANITE Promotes Bone Regeneration in Microgravity

Elucid Raises $55 Million to Expand AI-Powered Cardiovascular Imaging Platform

Scholar Rock Gets FDA Fast Track Designation for Apitegromab in FSHD as Phase 2 Trial Begins

EDITOR PICKS

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

THIS WEEK'S STORIES

TransCode Reports Preclinical Survival Benefit for TTX-MC138 in Breast Cancer Bone Metastasis

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Transfyr Launches Physical AI Platform for Science With $25 Million in Seed Funding

POPULAR CATEGORY

ABOUT US

FOLLOW US